期刊文献+

87例登革热住院病例不同病程的临床特征分析 被引量:10

Clinical features of different courses of 87 dengue fever inpatients
暂未订购
导出
摘要 目的分析登革热病例不同病程的临床特征,为早期发现和诊断登革热病例提供依据。方法收集广州市某医院2006年3-9月期间住院的登革热病例临床症状、血常规、血液生化检查、血清抗体等资料,并进行描述性统计分析。结果共分析87例登革热病例,发病第1天所有病例出现发热,热程中位数为6 d;73.56%(64/87)病例出现头痛;27.59%(24/87)的病例出现骨痛;仅2.30%(2/87)的病例出疹。统计40例出疹病例,疹程中位数为6 d。发病的第5天,19.54%(17/87)有皮疹表现,谷草转氨酶(AST)及谷丙转氨酶(ALT)升高检出率分别为86.67%(13/15)、46.67%(7/15);白细胞及血小板减少检出率分别为80.00%(12/15)、73.33%(11/15)。IgM在发病第5天阳性检出率为53.33%(8/15)。IgG在发病第8天阳性检出率为54.55%(6/11)。结论登革热的早期临床体征同其他感染性疾病不容易鉴别,诊断存在一定的困难。建议在登革热流行期,应综合登革热临床特征和实验室结果,在发病5 d内,密切注意以发热、头痛、AST升高、WBC减少、血小板减少的病人。 Objective To find clinical features of dengue fever inpatients in order to early detect and diagnose. Methods Information on clinical manifestations, blood routine and biochemical test, as well as serum antibody, were collected and analyzed by descriptive epidemiological methods among 87 dengue fever inpatients in a hospital. Results On the first day after onset, all cases had fever( ≥38℃ ) and median febrile period was 6 days. 73.56% (64/87) cases had headache, 27.59% (24/87) joint pain, while only 2.30% (2/87) cases had rash with median rash period 6 days. On the fifth days after onset, 19.54% (17/87) cases had rash. 86. 67% ( 13/15 ) ,46. 67% (7/15) had increased AST and ALT level. 80.00% ( 12/15 ) ,73.33% ( 11/15 ) observed WBC and PLT reduction. IgM antibody was detected in 53.33% (8/15) cases on the fifth days after onset likewise IgG antibody in 54.55% (6/11) on the eighth days after onset. Conclusions Early clinical diagnosis of dengue fever was difficult due to overlapping manifestation with other communicable diseases, and close attention should be paid to cases with fever, headache, AST increase, WBC and PLT decrease in the first 5 days during epidemic.
出处 《华南预防医学》 2007年第5期18-21,共4页 South China Journal of Preventive Medicine
关键词 登革热 临床特征 诊断 Dengue fever Clinical features Diagnosis
  • 相关文献

参考文献6

二级参考文献17

  • 1World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control, 2^nd edn. Geneva:WHO,1997.
  • 2Gibbons RV, Vaughn DW. Dengue: an escalation problem.BMJ, 2002,324: 1563-1566.
  • 3.登革热诊断标准及处理原则:中华人民共和国卫生部行业标准.[S].,2001.77-78.
  • 4Gubler DJ. Dengue and dengue haemorrhagic. Clin Microbiol Rev, 1998,11,480-496.
  • 5Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer,antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis, 2000, 181:2-9.
  • 6Kuo CH, Tai DI, Chang-CHIEN CS,et al. Liver biochemical tests and dengue fever. Am J Trop Med Hyg,1992,47,265-270.
  • 7Deparis X,Murgue B, Roche C, et al. Changing clinical and biological manifestations of dengue during the dengue-2 eidemic in French polynesia in 1996/1997-description and analysis in a prospective study. Tropical Medicine and International Health, 1998,3 : 859-865.
  • 8WHO.Dengue haemorrhagic fever: diagnosis, treatment,prevention and control(2nd)[].Geneva.1997
  • 9WHO.Dengue bulletin[].Geneva.1996
  • 10WHO.WHO report on global surveillance of epidemic-prone infectious diseases[].Geneva.2001

共引文献132

同被引文献81

引证文献10

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部